Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 11 May 2020 for American Renal Associates Holdings, Inc.. Read the official filing
Filing timeline
BuySaleChristopher J. Hocevar
Insider track record
Disclosed buys
0
Disclosed sells
2
Signal history
Christopher J. Hocevar: trading record in brief
Filings by Christopher J. Hocevar span 2 companies, the busiest being Cigna Corp and American Renal Associates Holdings, Inc. Between 24 February 2017 and 7 May 2020, the trades on record add up to 9 filings.
The open-market record consists of 2 sales worth €1.8M, with no purchase. Outside the open market, there are 5 share grants and 2 option exercises.
The newest entry dates from 11 May 2020: a share grant, in American Renal Associates Holdings, Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Christopher J. Hocevar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
18,679 shares0Common StockSEC:0001498068-20-000075:0
4,033 shares0Common Stock, $.25 Par ValueSEC:0001225208-18-005502:0
1,274 shares@ US$192.446.1% of flowCommon Stock, $.25 Par ValueSEC:0001225208-18-005502:1
2,759 shares@ US$191.8413.2% of flowCommon Stock, $.25 Par ValueSEC:0001225208-18-005502:2
6,389 shares@ US$120.9019.9% of flowCommon Stock, $.25 Par ValueSEC:0001225208-17-017742:0
4,775 shares@ US$78.049.6% of flowCommon Stock, $.25 Par ValueSEC:0001225208-17-017742:1
8,387 shares@ US$200.3243.3% of flowCommon Stock, $.25 Par ValueSEC:0001225208-17-017742:2
1,850 shares@ US$147.087.9% of flowCommon Stock, $.25 Par ValueSEC:0001225208-17-004980:1
5,336 shares0Common Stock, $.25 Par ValueSEC:0001225208-17-004980:0
9 of 9 declarations
